Denali Therapeutics Shares Fall in Premarket on Share Offering Price
Dow Jones12-10
By Adriano Marchese
Denali Therapeutics shares were lower in premarket trading Wednesday after it priced its share offering below current trading levels.
Shares were down 9.7% ahead of the morning bell at $17.75.
The biotechnology company said it will offer 9.1 million shares at a price of $17.50 apiece.
The stock has been under pressure in 2025, falling about 3.5% since the year began, and about 20% over the past 52 weeks.
The company also issued prefunded warrants to purchase 2.3 million shares at a stock price of $17.49.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
December 10, 2025 08:50 ET (13:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments